QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO., LTD.

Qinghai Spring Medicinal Resources Technology Co., Ltd.

600381

CNE0000017W0

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 16/07/2024 BST			5-day change	1st Jan Change
2.74 ^CNY	+4.98%		+27.44%	-64.55%

12:00am	Tranche Update on Qinghai Spring Medicinal Resources Technology Co., Ltd.'s Equity Buyback Plan announced on April 19, 2024.	CI
07-17	Qinghai Spring Medicinal Resources Technology Co., Ltd.'s Equity Buyback announced on April 19, 2024, has closed with 14,703,805 shares, representing 2.5% for CNY 33.74 million.	CI

Qinghai Spring Medicinal Resources Technology Co., Ltd.'s Equity Buyback announced on April 19, 2024, has closed with 14,703,805 shares, representing 2.5% for CNY 33.74 million.

July 16, 2024

The company closed its plan on July 17, 2024.

Latest news about Qinghai Spring Medicinal Resources Technology Co., Ltd.

Tranche Update on Qinghai Spring Medicinal Resources Technology Co., Ltd.'s Equity Buyback Plan announced on April 19, 2024.	17/07/2024	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd.'s Equity Buyback announced on April 19, 2024, has closed with 14,703,805 shares, representing 2.5% for CNY 33.74 million.	07-16	CI
Tranche Update on Qinghai Spring Medicinal Resources Technology Co., Ltd.'s Equity Buyback Plan announced on April 19, 2024.	07-01	CI
Qinghai Spring Medicinal Resources Technology's Unit Fined Over Misleading Advertising	06-27	MT
Qinghai Spring Medicinal Resources Technology Co., Ltd.(SHSE:600381) dropped from Shanghai Stock Exchange Composite Index	06-13	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd.(SHSE:600381) dropped from Shanghai Stock Exchange A Share Index	06-13	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd.(XSSC:600381) dropped from S&P Global BMI Index	05-09	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-22	CI
Qinghai Spring Medicinal Resources Technology Plans Shares Buyback of Up to 50 Million Yuan	04-19	MT
Qinghai Spring Medicinal Resources Technology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.	04-18	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. authorizes a Buyback Plan.	04-17	CI
Qinghai Spring Medicinal Resources Probed Over Misleading Ad for Rice Wine	03-19	MT
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/10/23	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd.(XSSC:600381) added to S&P Global BMI Index	17/09/23	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	27/08/23	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	28/04/23	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	30/08/22	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/04/22	CI
Beijing Life Capital Management Co., Ltd. completed the acquisition of a 5% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd. from Tibet Rongen Technology Co., Ltd.	19/12/21	CI
Beijing Life Capital Management Co., Ltd. signed the share transfer agreement to acquire a 5% stake in Qinghai Spring Medicinal Resources Technology Co., Ltd. from Tibet Rongen Technology Co., Ltd. for approximately CNY 200 million.	10/12/21	CI
Qinghai Spring Medicinal Resources Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/10/21	CI

Chart Qinghai Spring Medicinal Resources Technology Co., Ltd.

Duration

Period

Chart Qinghai Spring Medicinal Resources Technology Co., Ltd.

More charts

QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO.,LTD is a China-based company that principally engaged in the integrated development, utilization, production, sales and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Companyâs main products are the cordyceps sinensis series products under Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis and raw cordyceps sinensis. The Companyâs subsidiary is Qinghai Spring Pharmaceutical Resource Utilization Co Ltd.

Sector

Pharmaceuticals

Calendar

01/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
QINGHAI SPRING MEDICINAL RESOURCES TECHNOLOGY CO., LTD.	-64.55%	211M
DONG-E-E-JIAO CO.,LTD.	+7.30%	4.81B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-31.08%	3.6B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	-0.71%	3.09B
TASLY PHARMACEUTICAL GROUP CO., LTD	-24.32%	2.62B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-11.35%	2.27B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+34.19%	1.82B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+33.49%	1.41B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-15.07%	1.38B
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK	+40.95%	1.37B

Alternative Medicine